Gleevec 400 MG tablet 10S
Ended Awarded
- Contract number
- SPE2DB25FW82F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,864
Award facts
- Contract value 100% obligated
- $15,863.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Gleevec 400 mg tablets in quantities of 10 units, with a ceiling value of $15,863.96 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with a completion date of May 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs the work at its Corporate Office location in that same city. As a child contract, this delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026.
The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This prime indefinite delivery vehicle encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains, with the flexibility to serve customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Gleevec, a specialized oncology medication, demonstrates the breadth of AmerisourceBergen Drug Corp's federal medical supply portfolio under this strategically important contract mechanism.
Quick answers
Who was awarded contract SPE2DB25FW82F?
SPE2DB25FW82F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 1, 2025.
How much is contract SPE2DB25FW82F worth?
The government has obligated $15,864 on SPE2DB25FW82F.
Is contract SPE2DB25FW82F an order under another contract?
Yes. SPE2DB25FW82F is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FW82F competed?
The extent of competition for SPE2DB25FW82F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award